Tetraphenyl ethylene skeleton pyridine salt singlet oxygen type photosensitizer and application thereof in preparation of bacteriostatic preparation

A tetraphenylethylene skeleton pyridinium salt photosensitizer with AIE properties addresses the ACQ issue in PDT, enhancing ROS generation and broad-spectrum antibacterial efficacy against diverse bacterial strains, including drug-resistant ones.

CN119060039AActive Publication Date: 2024-12-03ANHUI UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411171004.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-12-03
Estimated Expiration
2044-08-26

AI Technical Summary

Technical Problem

Existing photosensitizers used in photodynamic therapy (PDT) for bacterial infections suffer from aggregation-induced quenching (ACQ), reducing their photochemical activity and ROS yield, limiting their effectiveness against bacterial resistance.

Method used

A tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer with aggregation-induced emission (AIE) characteristics is developed, enhancing fluorescence and ROS generation in aggregated states to improve antibacterial efficacy.

Benefits of technology

The AIE photosensitizer effectively generates ROS to inhibit the growth of various bacteria, including drug-resistant strains, offering a broad-spectrum antibacterial effect under normal conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060039A_ABST
    Figure CN119060039A_ABST
Patent Text Reader

Abstract

The invention discloses a tetraphenyl ethylene skeleton pyridinium salt singlet oxygen type photosensitizer and application thereof in preparation of a bacteriostatic preparation. The structural general formula of the tetraphenyl ethylene skeleton pyridinium salt singlet oxygen type photosensitizer is as shown in the following formula (I): # imgabs0 #, wherein X is selected from one of I <->, Br <->, Cl <->, F <->, OH <->, NO3 <->, SHO3 <-> and PF6 <->; r1 is selected from an aromatic ring derivative electron-donating group; r2 is selected from one of alkyl, alkoxy, 4-boric acid phenyl and 4-methylphenylboronic acid pinacol ester. The photosensitizer combines the AIE fluorescence enhancement characteristic and the efficient ROS generation capacity, the bacteriostatic selectivity and the bacteriostatic efficiency are remarkably improved, and a new strategy is provided for APDT treatment of bacterial infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a photosensitizer and application thereof, and in particular to a tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer and antibacterial application thereof. Background Art

[0002] Bacterial infections pose a multi-dimensional threat to human health with far-reaching impacts. The routes of bacterial transmission are diverse and complex, including but not limited to the digestive tract, respiratory tract, and arthropods. Foodborne bacterial diseases often lead to mass gastrointestinal dysfunction, diarrhea, vomiting and other symptoms, which not only affect the quality of life of patients, but may also cause serious complications, the severity of which includes direct mortality, consumption of medical resources, aggravation of antibiotic resistance, and long-term impact on socioeconomics. Antibiotics are one of the main drugs for the treatment of bacterial infections, and they exert their therapeutic effects by inhibiting bacterial growth or killing bacteria. The widespread and inappropriate use of antibiotics has led to a global problem of bacterial resistance, which not only reduces the effectiveness of antibiotics, but also poses challenges to the development of alternative therapies, new drug research and development, and the formulation and implementation of public health policies.

[0003] Photodynamic therapy (PDT) is an innovative treatment method. PDT sterilization relies on photosensitizers to produce reactive oxygen species (ROS) under light irradiation, which damages the structure and function of bacterial cells and achieves targeted inactivation of bacteria. It is an effective alternative or complementary treatment strategy in dealing with bacterial resistance. The properties of photosensitizers, including photochemical stability, light absorption characteristics, and ROS generation efficiency, are crucial to the efficacy of PDT. The aggregation of traditional photosensitizers in vivo may lead to aggregation-induced quenching (ACQ), which reduces photochemical activity and ROS yield, and therefore limits their application.

[0004] Aggregation-induced emission (AIE) is a unique photophysical phenomenon that is fundamentally different from the ACQ phenomenon. AIEgen exhibits weak fluorescence or no fluorescence in dilute solutions or in a single molecule state, while the fluorescence is significantly enhanced in an aggregated state. AIEgen has the ability to efficiently generate ROS in an aggregated state, thereby achieving the inactivation of bacteria, showing significant application potential in antibacterial photodynamic therapy (APDT).

[0005] The inventor conducted the following search on the relevant contents of this application:

[0006] 1. Search results from http: / / scholar.google.com: (2024 / 7 / 8)

[0007]

[0008]

[0009] 2. CNKI search results: (2024 / 7 / 8)

[0010] Search method 1:

[0011] Title-----Antibacterial activity of AIE-active pyridine-phenylborate singlet oxygen type reactive oxygen photosensitizers No related literature.

[0012] Title-----Antibacterial activity of singlet oxygen type reactive oxygen photosensitizers based on pyridine-phenylborate There is no relevant literature.

[0013] Title-----Antibacterial activity of singlet oxygen type reactive oxygen photosensitizers There is no relevant literature.

[0014] Search method 2:

[0015] Full text-----The antibacterial activities of the AIE-active pyridine-phenyl borate-based singlet oxygen-type reactive oxygen photosensitizers are 2 items, both of which are unrelated to the target compounds.

[0016] Full text-----Antibacterial activity of singlet oxygen type reactive oxygen photosensitizers based on pyridine-phenyl borate No related literature.

[0017] Full text---327 antibacterial activities of singlet oxygen type reactive oxygen photosensitizers were found, none of which were related to the target compounds.

[0018] Search method three:

[0019] Keywords----AIE activity Pyridine-phenyl borate type singlet oxygen type reactive oxygen photosensitizer Antibacterial activity No related literature.

[0020] Keywords-----Antibacterial activity of singlet oxygen type reactive oxygen photosensitizer of pyridine-phenyl borate No related literature.

[0021] Keywords-----Antibacterial activity of singlet oxygen type reactive oxygen photosensitizers No relevant literature. Summary of the invention

[0022] In view of the deficiencies of the above-mentioned prior art, the present invention provides a tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer and its antibacterial application. The present invention uses tetraphenylethylene as the structural skeleton to develop a type of pyridinium salt singlet oxygen type ROS photosensitizer with AIE characteristics, providing an innovative application strategy for bacterial inactivation. This type of photosensitizer combines the AIE fluorescence enhancement characteristics with the efficient ROS generation ability, significantly improving the antibacterial selectivity and antibacterial efficiency, and providing a new strategy for APDT treatment of bacterial infection.

[0023] The tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer of the present invention has a general structural formula as shown in the following formula (I):

[0024]

[0025] Where: X is selected from iodide ion I - 、Br - 、Chloride ion Cl - 、Fluoride ion F - 、hydroxyl ion OH - 、Nitrate NO3 - 、Sulfonate ion SHO3 - , and hexafluorophosphate ion PF6 - R1 is an electron-donating group of an aromatic ring derivative, including but not limited to diphenylamine, triphenylamine, cyclooctatetrathiophene, tetraphenylethylene, etc. R2 is selected from alkyl, alkoxy, 4-boronic acid phenyl, 4-methylphenylboronic acid pinacol ester, etc.

[0026] More preferably, it is one of the structures shown in the following formula AL:

[0027]

[0028]

[0029] Furthermore, the R1 is a tetraphenylethylene group, the R2 is a 4-boronic acid benzyl group, and X is a bromide ion.

[0030] The invention discloses an application of a tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer in the preparation of an antibacterial preparation.

[0031] The antibacterial preparation has an inhibitory effect on bacteria under light conditions.

[0032] The bacteria include one or more of the gram-negative bacteria Escherichia coli (E. coli), the gram-positive bacteria Bacillus megaterium (B. megaterium), Bacillus cereus (B. cereus), Bacillus subtilis (B. subtilis) WB-800 subspecies, Bacillus subtilis (B. subtilis) 1285 subspecies, and Staphylococcus aureus (S. aureus).

[0033] The present invention also uses an unsalted pyridine derivative as a control of a tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer, and its structure is shown in the following formula M:

[0034]

[0035] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0036] 1. The present invention synthesized a new singlet oxygen-type ROS material system with AIE performance.

[0037] 2. The present invention uses a simple and effective method to synthesize singlet oxygen type photosensitizer.

[0038] 3. The singlet oxygen type photosensitizer of the present invention can inhibit the growth of various bacteria at normal temperature and pressure and has a broad-spectrum antibacterial effect.

[0039] 4. The singlet oxygen-type photosensitizer of the present invention has a strong antibacterial effect on Bacillus cereus, a food-borne pathogen that can cause food poisoning. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 The middle left figure shows the fluorescence emission spectra of TBPB (10 μM) in DMSO / Tol (v / v) mixed solvents with increasing toluene content, λ ex =400nm; the right figure shows the change of fluorescence intensity of TBPB (10μM) in DMSO / Tol (v / v) mixed solvent with the toluene content of the solution.

[0041] Figure 2 (A) shows the fluorescence intensity of DCF-H solution containing control M (4μM) and Ce6 (4μM), TBPB (4μM) and Ce6 (4μM) changing with irradiation time under white light irradiation conditions. The DCF-DA fluorescent probe was used to confirm that the reactive oxygen production efficiency of TBPB was much higher than that of M. (B) shows the degradation rate of ABDA solution containing M (10μM) and RB (10μM), TBPB (10μM) and RB (10μM) under white light irradiation conditions. ABDA was used to confirm that both M and TBPB produced singlet oxygen-type ROS species.

[0042] Figure 3The inactivation effect of TBPB on different bacteria in the dark and light, including Gram-negative bacteria Escherichia coli (E. coli), Gram-positive bacteria Bacillus megaterium (B. megaterium), Bacillus cereus (B. cereus) and Bacillus subtilis (B. subtilis, 168, 1285, wb800 three subtypes), Methicillin-Resistant Staphylococcus aureus (MRSA). [TBPB] = 50 μM, Scale bar = 2 cm, light energy density: 26 mW cm -2 , lighting time: 30 minutes.

[0043] Figure 4 The inactivation effect of different concentrations of TBPB on Bacillus cereus in the dark and light. Scale bar = 2 cm, light energy density: 26 mW cm -2 , lighting time: 30 minutes.

[0044] Figure 5 The inactivation effect of TBPB on Bacillus cereus at different illumination times. [TBPB] = 50 μM, Scale bar = 2 cm, light energy density: 26 mW cm -2 .

[0045] Figure 6 The results of M plate experiments on different bacteria in the dark and light, including Gram-negative bacteria Escherichia coli (E. coli), Gram-positive bacteria Bacillus cereus (B. cereus) and Methicillin-Resistant Staphylococcus aureus (MRSA). [M] = 50 μM, Scale bar = 2 cm, light energy density: 26 mW cm -2 , lighting time: 30 minutes.

[0046] Figure 7 The fluorescence imaging effects of M and TBPB on different bacteria, including Gram-positive Escherichia coli (E. coli), Gram-negative Bacillus cereus (B. cereus) and Methicillin-Resistant Staphylococcus aureus (MRSA). [M] = 10 μM, λ ex =405nm,λ em =590-690nm.Scale bar=10μm.[TBPB]=10μM,λex =405nm,λ em =600-700nm.Scale bar=10μm. DETAILED DESCRIPTION

[0047] The present invention is further described in detail below in conjunction with embodiments and drawings, but the embodiments of the present invention are not limited thereto.

[0048] Example 1: Synthesis of Pyridinium Salt Singlet Oxygen Type Reactive Oxygen Photosensitizer (TBPB)

[0049]

[0050] 1. Synthesis of intermediate TPE-BTZ-Br

[0051]

[0052] In a 100mL round-bottom flask, the compound [1-(4-boronic acid ester phenyl)-1,2,2-triphenyl] ethylene (1g, 2.66mmol) and 4,7-dibromobenzo[c]-1,2,5-thiadiazole (1.17g, 3.99mmol) were dissolved in 24mL tetrahydrofuran, and 6mL potassium carbonate aqueous solution (2M) and tetrakis(triphenylphosphine)palladium were added. The reaction was refluxed under a nitrogen atmosphere and tracked by TLC. After the reaction was completed, it was cooled to room temperature, and water and dichloromethane were added for extraction. The organic layer was dried over anhydrous sodium sulfate, filtered, and the organic layer was spin-dried. The substance was separated and purified by column chromatography (developing solvent: petroleum ether: dichloromethane = 15:1, V / V), and vacuum dried to obtain a light yellow product. 1 H NMR (600 MHz, d6-DMSO), δ (ppm): 8.04 (d, J = 6.00 Hz, 1H), 7.76 (d, J = 6.00 Hz, 2H), 7.70 (d, J = 6.00 Hz, 1H), 7.16-7.07 (m, 11H), 7.04 (d, J = 12.00 Hz, 2H), 7.00 (d, J = 6.00 Hz, 2H), 6.96 (d, J = 6.00 Hz, 2H). MS (ESI): theoretical value (C 32 H 21 BrN2S) 545.50, experimental value m / z: 545.0673.

[0053] 2. Synthesis of control substance M

[0054]

[0055] In a 100 mL round flask, add the intermediate TPE-BTZ-Br (500 mg, 916.59 μmol) and 4-pyridine boronic acid (169 mg, 1.37 mmol) and 24 mL THF. After dissolving, add 63 mg tetrakis(triphenylphosphine)palladium and 2M K2CO3 solution (6 mL). Under a nitrogen atmosphere, reflux the reaction. TLC is used to track the reaction. After completion, extract with CH2Cl2, dry the organic layer with anhydrous Na2SO4, filter and spin dry, and purify with silica gel column chromatography (developing solvent: DCM:EA=9:1, V / V) to obtain an orange reference substance M. 1 HNMR (600 MHz, d6-DMSO): δ 8.38 (d, J = 12.00 Hz, 1H), 8.00 (d, J = 6.00 Hz, 1H), 7.88 (d, J = 6.0 Hz, 2H), 7.19-7.10 (m, 13H), 7.09-7.06 (m, 4H), 7.04 (d, J = 12.00 Hz, 2H), 6.98 (d, J = 6.00 Hz, 2H). MS (ESI): theoretical value (C 37 H 25 N3S) 543.69, experimental value m / z: [TBP+H] + 544.18.

[0056] 3. Synthesis of target product TBPB

[0057]

[0058] In a 25 mL round flask, add reference substance M (100 mg, 0.22 mmol), 4-bromomethylphenylboronic acid pinacol ester (65 mg, 0.22 mmol) and 5 mL DMF, and reflux under nitrogen atmosphere. After the reaction is completed, add excess toluene, a black precipitate is precipitated, and filtered to obtain a black solid product TBPB. 1 HNMR (700 MHz, d6-DMSO): δ 8.75 (d, J = 7.00 Hz, 1H), 8.12 (d, J = 7.00 Hz, 1H), 8.06 (d, J = 7.00 Hz, 1H), 7.97 (m, J = 7.00 Hz, 2H), 7.86 (t, J = 10.50 Hz, 3H), 7.22-7.12 (m, 14H), 7.09 (d, J = 7.00 Hz, 3H), 7.06 (d, J = 7.00 Hz, 2H), 7.02 (d, J = 7.00 Hz, 2H), 1.23 (s, 2H). MS (ESI): theoretical value (C 29 H 20 N4S) 758.54, experimental value m / z: [TBPB-Br] + 678.24.

[0059] Example 2: Characterization of AIE properties of pyridinium salt singlet oxygen type reactive oxygen photosensitizer (TBPB)

[0060] Figure 1 The fluorescence spectra of the material obtained in Example 1 under different toluene content conditions are shown in the figure. As can be seen from the figure, the example material basically does not emit light in pure dimethyl sulfoxide solvent. With the addition of poor solvent toluene, the fluorescence begins to gradually increase. When the toluene content is increased to 99%, the fluorescence intensity of TBPB reaches the strongest state, indicating that the TBPB photosensitizer has AIE characteristics.

[0061] Example 3: Identification of Reactive Oxygen Species of Singlet Oxygen Type Reactive Oxygen Photosensitizer (TBPB)

[0062] Figure 2 Identification of active oxygen species based on the material obtained in Example 1. Figure 2 A It can be seen that when the DCFDA fluorescent probe is used to detect reactive oxygen, after adding the photosensitizer TBPB and the control M and irradiating with white light, the DCF fluorescence intensity is significantly enhanced, indicating that both M and TBPB can produce reactive oxygen. By comparing the changes in fluorescence intensity of the two groups, it can be observed that the reactive oxygen production efficiency of TBPB is significantly higher than that of M. Figure 2 B used 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA) to directly prove that M and TBPB produce singlet oxygen-type reactive oxygen species. ABDA was used as a singlet oxygen scavenger. After light activation, the ABDA+M group and the ABDA+TBPB group showed a significant decrease in ABDA ultraviolet absorption. This result shows that both M and TBPB produce singlet oxygen-type ROS species under light conditions.

[0063] Example 4: Inactivation of bacteria by pyridinium salt singlet oxygen type reactive oxygen photosensitizer (TBPB)

[0064] Figure 3 The results of the inactivation performance of TBPB on different bacteria under dark and light conditions were shown in Figure 2. The experimental bacteria included Gram-negative Escherichia coli (E. coli), Gram-positive Bacillus megaterium (B. megaterium), Bacillus cereus (B. cereus), Bacillus subtilis (B. subtilis) WB-800 subspecies and Bacillus subtilis (B. subtilis) 1285 subspecies, and Methicillin-Resistant Staphylococcus aureus (MRSA). After culturing the bacteria for 18 hours, 50 μM TBPB was added to the bacterial solution, and the solution was irradiated with white light for 30 minutes. 1×105 200 μL of CFU / mL bacterial solution was evenly coated on solid culture medium (LB agar) and cultured at 37°C for 18 hours. From the results, it can be seen that TBPB can inhibit the growth of bacteria within the scope of investigation, has a broad-spectrum antibacterial activity, and also has a strong antibacterial effect on drug-resistant bacteria MRSA. TBPB can completely kill Bs and Bm and has bactericidal properties against them.

[0065] Figure 4 The results of the inactivation test of different concentrations of TBPB on Bacillus cereus in the dark and in the light. After the bacteria were cultured for 18 hours, 10, 30, 50, 70, and 90 μM TBPB were added to the bacterial solution, and then irradiated with white light for 30 minutes. 1×10 5 200 μL of CFU / mL bacterial solution was evenly spread on solid culture medium (LB agar) and cultured at 37°C for 18 hours. From the results, it can be seen that 10 μM TBPB can completely inactivate Bacillus cereus.

[0066] Figure 5 The results of the inactivation experiment of TBPB on Bacillus cereus under different illumination times. After culturing the bacteria for 18 hours, 50 μM TBPB was added to the bacterial solution and irradiated with white light for 5, 10, 15, 20, 25, and 30 minutes, respectively. 1×10 5 200 μL of CFU / mL bacterial solution was evenly spread on solid culture medium (LB agar) and cultured at 37°C for 18 hours. From the results, it can be seen that TBPB can completely inactivate Bacillus cereus after 15 minutes of light exposure.

[0067] Example 5: Inactivation of Bacteria by Control M

[0068] Figure 6 The results of the inactivation test of the control substance M on different bacteria under dark and light conditions. The experimental bacteria include Gram-negative bacteria Escherichia coli (E.coli), Gram-positive bacteria Bacillus cereus (B.cereus), and Methicillin-Resistant Staphylococcus aureus (MRSA). After culturing the bacteria for 18 hours, 50 μM of the control substance M was added to the bacterial solution, and then irradiated with white light for 30 minutes. 1×10 5 200 μL of CFU / mL bacterial solution was evenly spread on solid culture medium (LB agar) and cultured at 37°C for 18 hours. From the results, it can be seen that M has no antibacterial properties against both Gram-positive and Gram-negative bacteria.

[0069] Example 6: Fluorescence imaging of bacteria by singlet oxygen type reactive oxygen photosensitizer TBPB and control substance M

[0070] Figure 7 The fluorescence imaging of TBPB and the control substance M on various bacteria, including Gram-negative bacteria Escherichia coli (E.coli), Gram-positive bacteria Bacillus cereus (B.cereus) and Methicillin-Resistant Staphylococcus aureus (MRSA). After culturing the bacteria for 18 hours, 10μM TBPB and 10μM control substance M were added to the bacterial solution, respectively, and then acted at 37°C for 10 minutes, washed with PBS three times, and imaged using a laser confocal microscope. From the results, it can be seen that TBPB can be evenly distributed on the surface of bacteria to achieve imaging of bacterial morphology, while the control substance M cannot interact with bacteria and is difficult to perform fluorescence imaging, which is also the reason why M has no antibacterial effect.

Claims

1. A tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer, characterized in that Its general structural formula is shown in the following formula (I): Where: X is selected from I - Br - , Cl - 、F - OH - 、NO3 - 、SHO3 - PF6 - R1 is selected from an electron-donating group of an aromatic ring derivative; R2 is selected from an alkyl group, an alkoxy group, 4-boronic acid phenyl, and 4-methylphenylboronic acid pinacol ester.

2. The tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer according to claim 1, characterized in that: R1 is selected from the group consisting of diphenylamine, triphenylamine, cyclooctatetrathiophene, and tetraphenylethylene.

3. The tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer according to claim 1, characterized in that It is one of the structures shown in the following formula AL:

4. The tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer according to claim 1, characterized in that The R1 is a tetraphenylethylene group, the R2 is a 4-boronic acid benzyl group, and X is a bromide ion.

5. Use of the tetraphenylethylene skeleton pyridinium salt singlet oxygen type photosensitizer according to claim 1 in the preparation of antibacterial preparations.

6. The use according to claim 5, characterized in that: The antibacterial preparation has an inhibitory effect on bacteria under light conditions.

7. The use according to claim 6, characterized in that: The bacteria include one or more of Gram-negative bacteria Escherichia coli, Gram-positive bacteria Bacillus megaterium, Bacillus cereus, Bacillus subtilis subspecies WB-800, Bacillus subtilis subspecies 1285, and Staphylococcus aureus.

Citation Information

Patent Citations

  • AIE photosensitizer based on pyridinium salt as well as preparation method and application of AIE photosensitizer

    CN114539239A

  • Photosensitizer, preparation method and application thereof, and preparation method and application of antibacterial fiber

    CN116804006A

  • Pyridine salt singlet oxygen type active oxygen photosensitizer as well as preparation method and application thereof

    CN117624035A